# Amanda Gett Chaperot

> Amanda Gett Chaperot is a Series B investor at Kurma Partners backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners)
- Location: Paris, France
- Total investments: 1
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/amgett/

Amanda Gett Chaperot is a Series B investor at Kurma Partners in Paris focused on Medical and Biopharma. Amanda Gett Chaperot is based out of Paris, Ile-de-France and is the Partner of Kurma Partners. Amanda previously worked at Seventure Partners as a Partner. Amanda Gett Chaperot attended the University of Sydney. Amanda Gett Chaperot has been received Best New Investigator Award.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nuevocor | Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts. | $45M | Series B | May 06, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [ClavystBio](https://shizune.co/investors/profile/clavystbio) — VC Fund, 1 deal together
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund, 1 deal together
- [Highlight Capital](https://shizune.co/investors/profile/highlight-capital-llc) — VC Fund, 1 deal together
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund, 1 deal together

## About Kurma Partners

VC Fund · Paris, France

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

5 contacts available at Kurma Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alain Horvais | Partner | https://shizune.co/investors/profile/alain-horvais |
| Amanda Gett Chaperot | Partner | https://shizune.co/investors/profile/amanda-gett |
| Amine Marouf | Principal | https://shizune.co/investors/profile/amine-marouf |
| Peter Neubeck | Partner | https://shizune.co/investors/profile/peter-neubeck |
| Philippe Peltier | Partner | https://shizune.co/investors/profile/philippe-peltier |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Amanda Gett Chaperot invest in?

Amanda Gett Chaperot invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co